Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn’s disease: an overview and update | Frontline Gastroenterology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Colorectal

Review

Anti-Mycobacterium paratuberculosis (MAP) therapy for Crohn’s disease: an overview and update

Online download statistics by month:

Online download statistics by month: July 2020 to June 2022

	Abstract	Full	Pdf
Jul 2020	357	10	14
Aug 2020	396	6	14
Sep 2020	139	4	14
Oct 2020	385	18	39
Nov 2020	334	6	26
Dec 2020	346	17	11
Jan 2021	382	8	7
Feb 2021	309	13	20
Mar 2021	310	21	16
Apr 2021	371	7	15
May 2021	100	5	7
Jun 2021	20	7	8
Jul 2021	9	5	13
Aug 2021	50	22	23
Sep 2021	55	18	14
Oct 2021	336	17	16
Nov 2021	312	11	4
Dec 2021	168	8	3
Jan 2022	239	3	7
Feb 2022	159	3	4
Mar 2022	303	5	5
Apr 2022	336	14	11
May 2022	300	5	1
Jun 2022	268	12	7
Total	5984	245	299